These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24423476)

  • 81. 2-year results of paclitaxel-eluting balloons for femoropopliteal artery disease: evidence from a multicenter registry.
    Micari A; Cioppa A; Vadalà G; Castriota F; Liso A; Marchese A; Grattoni C; Pantaleo P; Cremonesi A; Rubino P; Biamino G
    JACC Cardiovasc Interv; 2013 Mar; 6(3):282-9. PubMed ID: 23517840
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Drug-eluting stenting for femoropopliteal lesions, followed by cilostazol treatment, reduces stent restenosis in patients with symptomatic peripheral artery disease.
    Zen K; Takahara M; Iida O; Soga Y; Kawasaki D; Nanto S; Yokoi H; Matoba S;
    J Vasc Surg; 2017 Mar; 65(3):720-725. PubMed ID: 28073668
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Outcomes of Adjunctive Drug-Coated Versus Uncoated Balloon after Atherectomy in Femoropopliteal Artery Disease.
    Lee YJ; Ko YG; Ahn CM; Hong SJ; Kim JS; Kim BK; Choi D; Hong MK; Jang Y
    Ann Vasc Surg; 2020 Oct; 68():391-399. PubMed ID: 32339691
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
    Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
    Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
    Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions.
    Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
    J Endovasc Ther; 2014 Aug; 21(4):485-92. PubMed ID: 25101575
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A Pilot Study of Femoropopliteal Artery Revascularisation with a Low Dose Paclitaxel Coated Balloon: Is Predilatation Necessary?
    Schroeder H; Meyer DR; Lux B; Ruecker F; Martorana M; Miller LE; Duda S
    Eur J Vasc Endovasc Surg; 2017 Sep; 54(3):348-355. PubMed ID: 28778456
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Optimized drug-coated balloon angioplasty of the superficial femoral and proximal popliteal arteries using the Tack Endovascular System: TOBA III 12-month results.
    Brodmann M; Wissgott C; Brechtel K; Nikol S; Zeller T; Lichtenberg M; Blessing E; Gray W;
    J Vasc Surg; 2020 Nov; 72(5):1636-1647.e1. PubMed ID: 32414527
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Stellarex drug-coated balloon for treatment of femoropopliteal arterial disease-The ILLUMENATE Global Study: 12-Month results from a prospective, multicenter, single-arm study.
    Schroë H; Holden AH; Goueffic Y; Jansen SJ; Peeters P; Keirse K; Ito W; Vermassen F; Micari A; Blessing E; Jaff MR; Zeller T
    Catheter Cardiovasc Interv; 2018 Feb; 91(3):497-504. PubMed ID: 29086462
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.
    Soga Y; Iida O; Hirano K; Yokoi H; Nanto S; Nobuyoshi M
    J Vasc Surg; 2010 Sep; 52(3):608-15. PubMed ID: 20573476
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A Novel Sirolimus-Coated Balloon for the Treatment of Femoropopliteal Lesions: The SELUTION SFA Japan Trial.
    Iida O; Soga Y; Saito S; Mano T; Hayakawa N; Ichihashi S; Kawasaki D; Suzuki K; Yamaoka T; Fujihara M; Nakama T; Nakamura M; Horie K; Shah T; Lansky A; Kozuki A
    JACC Cardiovasc Interv; 2024 Jul; 17(13):1547-1556. PubMed ID: 38842992
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Stent-grafts are the best way to treat complex in-stent restenosis lesions in the superficial femoral artery: 24-month results from a multicenter randomized trial.
    Bosiers M; Deloose K; Callaert J; Verbist J; Hendriks J; Lauwers P; Schroë H; Lansink W; Scheinert D; Schmidt A; Zeller T; Beschorner U; Noory E; Torsello G; Austermann M; Wauters J
    J Cardiovasc Surg (Torino); 2020 Oct; 61(5):617-625. PubMed ID: 33231029
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Efficacy of two different self-expanding nitinol stents for atherosclerotic femoropopliteal arterial disease (SENS-FP trial): study protocol for a randomized controlled trial.
    Park SH; Rha SW; Choi CU; Kim EJ; Oh DJ; Cho YH; Choi WG; Lee SJ; Kim YH; Choi SH; Kim WH; Kim KC; Cho JH; Kim JH; Kim SM; Bae JH; Bong JM; Kang WY; Baek JY; Seo JB; Chung WY; Park MW; Her SH; Suh J; Kim MW; Kim YJ; Choi HJ; Soh JW;
    Trials; 2014 Sep; 15():355. PubMed ID: 25208688
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Endovascular Treatment of Long Superficial Femoral Artery-Chronic Total Occlusions Using the Gogo Catheter With IVUS Via a Popliteal Puncture Method Is Effective, Safe, and Useful.
    Nakamura S; Rokutanda T; Kurokawa H; Onoue Y
    Vasc Endovascular Surg; 2020 Apr; 54(3):225-232. PubMed ID: 31896318
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Balloon Angioplasty Versus Bailout Stenting for Isolated Chronic Total Occlusions in the Popliteal Artery.
    Elens M; Verhelst R; Mastrobuoni S; Bosiers MJ; Possoz J; Lacroix V; Astarci P
    Vasc Endovascular Surg; 2019 Feb; 53(2):126-131. PubMed ID: 30466371
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Patterns of femoropopliteal recurrence after routine and selective stenting endoluminal therapy.
    Kiguchi MM; Marone LK; Chaer RA; Winger DG; Shi ZY; Celis RI; Makaroun MS; Rhee RY
    J Vasc Surg; 2013 Jan; 57(1):37-43. PubMed ID: 22975333
    [TBL] [Abstract][Full Text] [Related]  

  • 97. MagicTouch PTA Sirolimus Coated Balloon for Femoropopliteal and Below the Knee Disease: Results From XTOSI Pilot Study Up To 12 Months.
    Choke E; Tang TY; Peh E; Damodharan K; Cheng SC; Tay JS; Finn AV
    J Endovasc Ther; 2022 Oct; 29(5):780-789. PubMed ID: 34911383
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Clinical Safety and Efficacy of Rotational Atherectomy in Japanese Patients with Peripheral Arterial Disease Presenting Femoropopliteal Lesions: The J-SUPREME and J-SUPREME II Trials.
    Iida O; Urasawa K; Shibata Y; Yamamoto Y; Ando H; Fujihara M; Nakama T; Miyashita Y; Mori S; Diaz-Cartelle J; Soga Y
    J Endovasc Ther; 2022 Apr; 29(2):240-247. PubMed ID: 34510954
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Outcomes following treatment of femoropopliteal in-stent restenosis: a single center experience.
    Yeo KK; Malik U; Laird JR
    Catheter Cardiovasc Interv; 2011 Oct; 78(4):604-8. PubMed ID: 21567880
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Infrapopliteal run-off and the outcome of femoropopliteal percutaneous transluminal angioplasty.
    Salapura V; Blinc A; Kozak M; Jezovnik MK; Pohar Perme M; Berden P; Kuhelj D; Kljucevsek T; Popovic P; Stankovic M; Vrtovec M; Surlan M
    Vasa; 2010 May; 39(2):159-68. PubMed ID: 20464672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.